{"id":"W1995328364","doi":"10.1517/14712590802666397","title":"Aflibercept (AVE0005): an alternative strategy for inhibiting tumour angiogenesis by vascular endothelial growth factors","year":2009,"lang":"en","type":"review","venue":"Expert Opinion on Biological Therapy","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Aflibercept; Angiogenesis; Cancer research; Decoy; Vascular endothelial growth factor; Tyrosine kinase; Receptor tyrosine kinase; Metastasis; Medicine; Cancer; VEGF receptors; Receptor; Internal medicine; Bevacizumab; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002844138,0.0006255854,0.0007824479,0.001170467,0.0001484,0.000550259,0.0006450081,0.0009139891,0.00233767],"category_scores_gemma":[0.0001647467,0.0001385007,0.0003714159,0.0007781145,0.0002444322,0.0006168396,0.0002525414,0.001231458,0.001868442],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005606779,"about_ca_system_score_gemma":0.000326878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004835229,"about_ca_topic_score_gemma":0.001021039,"domain_scores_codex":[0.9998986,0.00001715722,0.000009962419,0.00001863253,0.00004063797,0.0000149679],"domain_scores_gemma":[0.9999498,0.00001383485,0.00001528587,0.000001713408,0.000009702622,0.000009668593],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002908251,0.0001702741,0.0001934693,0.005194067,0.00008182262,0.0008342807,0.00003685281,0.0004121083,0.01861665,0.002601133,0.01560892,0.9559596],"study_design_scores_gemma":[0.0003582529,0.0008731217,0.001554169,0.0009120181,0.0001148526,0.01076834,0.00002881847,0.0003605741,0.01081275,0.001429451,0.9727526,0.00003507286],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002487971,0.9910573,0.0009999172,0.0005852947,0.0003893849,0.00002528255,0.00005245955,0.0000330384,0.004369333],"genre_scores_gemma":[0.01850847,0.9717206,0.001914612,0.001022702,0.0004281655,0.00004832463,0.0002411124,0.000006400139,0.0061097],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00233767,"threshold_uncertainty_score":0.007820249,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1281319538255109,"score_gpt":0.3852148239328217,"score_spread":0.2570828701073108,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}